A detailed history of Independence Bank Of Kentucky transactions in Novo Nordisk A S stock. As of the latest transaction made, Independence Bank Of Kentucky holds 2,350 shares of NVO stock, worth $330,010. This represents 0.09% of its overall portfolio holdings.

Number of Shares
2,350
Previous 2,125 10.59%
Holding current value
$330,010
Previous $219,000 37.44%
% of portfolio
0.09%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 16, 2024

BUY
$102.11 - $135.92 $22,974 - $30,581
225 Added 10.59%
2,350 $301,000
Q4 2023

Jan 23, 2024

BUY
$87.78 - $105.45 $164,587 - $197,718
1,875 Added 750.0%
2,125 $219,000
Q3 2023

Oct 16, 2023

BUY
$90.94 - $199.54 $13,641 - $29,931
150 Added 150.0%
250 $22,000
Q4 2019

Jan 31, 2020

BUY
$49.86 - $58.26 $4,986 - $5,826
100 New
100 $6,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $317B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Independence Bank Of Kentucky Portfolio

Follow Independence Bank Of Kentucky and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Independence Bank Of Kentucky, based on Form 13F filings with the SEC.

News

Stay updated on Independence Bank Of Kentucky with notifications on news.